Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Events & presentations

22 Jan 2018 - 25 Jan 2018

Phacilitate Cell & Gene Therapy World, Miami, US

11 Jan 2018 - 12 Jan 2018

Oddo BHF Forum, Lyon, France

08 Jan 2018 - 11 Jan 2018

JP Morgan 36th Annual Healthcare Conference, San Francisco (CA), USA

13 Dec 2017

Guggenheim Securities 5th Annual Boston Healthcare Conference 2017, Boston, MA, USA

14 Nov 2017 - 15 Nov 2017

The Stifel Nicolaus Weisel Healthcare Conference 2017, New York, NY, USA

11 Nov 2017 - 14 Nov 2017

American Academy of Ophthalmology, New Orleans (LA)

09 Nov 2017

Ophthalmology Innovation Summit @ AAO, New Orleans (LA)

17 Oct 2017 - 20 Oct 2017

ESGCT, Berlin, Germany

10 Oct 2017

Chardan Inaugural Gene Therapy Conference, NYC (US)

27 Sep 2017 - 28 Sep 2017

5th Annual Targeting Ocular Diseases, Boston (MA)

  • View previous 9 articles
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page